219 related articles for article (PubMed ID: 9569179)
1. Ins405AsnPro mutation in the von Willebrand factor propeptide in recessive type 2A (IIC) von Willebrand's disease.
Holmberg L; Karpman D; Isaksson C; Kristoffersson AC; Lethagen S; Schneppenheim R
Thromb Haemost; 1998 Apr; 79(4):718-22. PubMed ID: 9569179
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand disease.
Lanke E; Kristoffersson AC; Philips M; Holmberg L; Lethagen S
Thromb Haemost; 2008 Aug; 100(2):211-6. PubMed ID: 18690339
[TBL] [Abstract][Full Text] [Related]
3. Laboratory and molecular characteristics of recessive von Willebrand disease type 2C (2A subtype IIC) of variable severity due to homozygous or double heterozygous mutations in the D1 and D2 domains.
Michiels JJ; Gadisseur A; van der Planken M; Schroyens W; Berneman Z
Acta Haematol; 2009; 121(2-3):111-8. PubMed ID: 19506357
[TBL] [Abstract][Full Text] [Related]
4. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
5. Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease.
Baronciani L; Federici AB; Cozzi G; La Marca S; Punzo M; Rubini V; Canciani MT; Mannucci PM
Haemophilia; 2008 May; 14(3):549-55. PubMed ID: 18328061
[TBL] [Abstract][Full Text] [Related]
6. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of von Willebrand disease.
Mazurier C; Ribba AS; Gaucher C; Meyer D
Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
[TBL] [Abstract][Full Text] [Related]
8. New mutations in exon 28 of the von Willebrand factor gene detected in patients with different types of von Willebrand's disease.
Casaña P; Martínez F; Haya S; Tavares A; Aznar JA
Haematologica; 2001 Apr; 86(4):414-9. PubMed ID: 11325649
[TBL] [Abstract][Full Text] [Related]
9. Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor.
Hilbert L; Fressinaud E; Ribba AS; Meyer D; Mazurier C;
Thromb Haemost; 2002 Apr; 87(4):635-40. PubMed ID: 12008946
[TBL] [Abstract][Full Text] [Related]
10. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
11. A new candidate mutation (N528S) within the von Willebrand factor propeptide identified in a Japanese patient with phenotype IIC of von Willebrand disease.
Gaucher C; Uno H; Yamazaki T; Mashiba H; Mazurier C
Eur J Haematol; 1998 Aug; 61(2):145-8. PubMed ID: 9714529
[TBL] [Abstract][Full Text] [Related]
12. A new candidate missense mutation (Leu 1657 IIe) in an apparently asymptomatic type 2A (phenotype IIA) von Willebrand disease family.
Enayat MS; Guilliatt AM; Surdhar GK; Theophilus BD; Hill FG
Thromb Haemost; 2000 Sep; 84(3):369-73. PubMed ID: 11019957
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the genetic defects in recessive type 1 and type 3 von Willebrand disease patients of Italian origin.
Eikenboom JC; Castaman G; Vos HL; Bertina RM; Rodeghiero F
Thromb Haemost; 1998 Apr; 79(4):709-17. PubMed ID: 9569178
[TBL] [Abstract][Full Text] [Related]
14. Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide.
Hilbert L; Nurden P; Caron C; Nurden AT; Goudemand J; Meyer D; Fressinaud E; Mazurier C;
Thromb Haemost; 2006 Sep; 96(3):290-4. PubMed ID: 16953269
[TBL] [Abstract][Full Text] [Related]
15. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease.
Facey DA; Favaloro EJ; Koutts J; Berndt MC; Hertzberg MS
Br J Haematol; 1999 May; 105(2):538-41. PubMed ID: 10233434
[TBL] [Abstract][Full Text] [Related]
17. Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease.
Gallinaro L; Sartorello F; Pontara E; Cattini MG; Bertomoro A; Bartoloni L; Pagnan A; Casonato A
Thromb Haemost; 2006 Dec; 96(6):711-6. PubMed ID: 17139363
[TBL] [Abstract][Full Text] [Related]
18. Understanding von Willebrand's disease from gene defects to the patients.
Zhang Z; Blombäck M; Anvret M
J Intern Med Suppl; 1997; 740():115-9. PubMed ID: 9350192
[TBL] [Abstract][Full Text] [Related]
19. Autosomal recessive von Willebrand disease associated with compound heterozygosity for a novel nonsense mutation (2908 del C) and the missense mutation C2362F: definite evidence for the non-penetrance of the C2362F mutation.
Castaman G; Bertoncello K; Bernardi M; Eikenboom JC; Budde U; Rodeghiero F
Am J Hematol; 2007 May; 82(5):376-80. PubMed ID: 17109387
[TBL] [Abstract][Full Text] [Related]
20. L1503R is a member of group I mutation and has dominant-negative effect on secretion of full-length VWF multimers: an analysis of two patients with type 2A von Willebrand disease.
Kashiwagi T; Matsushita T; Ito Y; Hirashima K; Sanda N; Fujimori Y; Yamada T; Okumura K; Takagi A; Murate T; Katsumi A; Takamatsu J; Yamamoto K; Naoe T; Kojima T
Haemophilia; 2008 May; 14(3):556-63. PubMed ID: 18397285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
